Patricia J. Mclaughlin
#132,846
Most Influential Person Now
Patricia J. Mclaughlin's AcademicInfluence.com Rankings
Download Badge
Biology
Why Is Patricia J. Mclaughlin Influential?
(Suggest an Edit or Addition)Patricia J. Mclaughlin's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The biology of the opioid growth factor receptor (OGFr) (2002) (292)
- Increased brain size and cellular content in infant rats treated with an opiate antagonist. (1983) (216)
- Naltrexone modulates tumor response in mice with neuroblastoma. (1983) (209)
- Identification of opioid peptides regulating proliferation of neurons and glia in the developing nervous system (1991) (168)
- Vitamin E content of foods. (1979) (143)
- Endogenous opioid systems and the regulation of dendritic growth and spine formation (1989) (141)
- Endogenous opioids regulate dendritic growth and spine formation in developing rat brain (1987) (140)
- Naltrexone modulates body and brain development in rats: a role for endogenous opioid systems in growth. (1984) (124)
- Distribution of enkephalin immunoreactivity in germinative cells of developing rat cerebellum. (1985) (121)
- Opioid receptors and endogenous opioids in diverse human and animal cancers. (1987) (115)
- Immunolocalization of tumour necrosis factor-α (TNF-α) in the placental bed of normotensive and hypertensive human pregnancies (1996) (108)
- Effect of biomaterial surface charge on the inflammatory response: evaluation of cellular infiltration and TNF alpha production. (1996) (105)
- The OGF-OGFr axis utilizes the p16INK4a and p21WAF1/CIP1 pathways to restrict normal cell proliferation. (2009) (101)
- Endogenous opioids regulate cell proliferation in the retina of developing rat (1991) (96)
- Endogenous opioid systems regulate growth of neural tumor cells in culture (1989) (95)
- Opioid antagonist-induced modulation of cerebral and hippocampal development: histological and morphometric studies. (1986) (94)
- Opioid antagonist (naltrexone) modulation of cerebellar development: histological and morphometric studies (1986) (92)
- Gastrin regulates growth of human pancreatic cancer in a tonic and autocrine fashion. (1996) (91)
- Opioids and the apoptotic pathway in human cancer cells (2003) (91)
- Use of topical insulin to normalize corneal epithelial healing in diabetes mellitus. (2007) (86)
- Human pancreatic cancer cell proliferation in tissue culture is tonically inhibited by opioid growth factor. (1999) (85)
- Endothelial cell activation by tumour necrosis factor‐alpha (TNF‐α and the development of pre‐eclampsia (1994) (83)
- Duration of opiate receptor blockade determines tumorigenic response in mice with neuroblastoma: a role for endogenous opioid systems in cancer. (1984) (81)
- Morphine and brain growth retardation in the rat. (1977) (79)
- Opioid growth factor and organ development in rat and human embryos (1999) (77)
- Opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers. (2009) (77)
- Regulation of human head and neck squamous cell carcinoma growth in tissue culture by opioid growth factor. (1999) (76)
- Naltrexone, an opioid antagonist, facilitates reepithelialization of the cornea in diabetic rat. (2002) (75)
- Naltrexone modulates growth in infant rats. (1983) (74)
- Cell proliferation of human ovarian cancer is regulated by the opioid growth factor-opioid growth factor receptor axis. (2009) (73)
- Opioid growth factor regulates the cell cycle of human neoplasias. (2000) (72)
- The OGF-OGFr axis utilizes the p21 pathway to restrict progression of human pancreatic cancer (2008) (71)
- The opioid growth factor-opioid growth factor receptor axis: homeostatic regulator of cell proliferation and its implications for health and disease. (2012) (69)
- Identification and characterization of CCK-B/gastrin receptors in human pancreatic cancer cell lines. (1994) (68)
- The opioid growth factor, [Met5]-enkephalin, and the zeta opioid receptor are present in human and mouse skin and tonically act to inhibit DNA synthesis in the epidermis. (1996) (68)
- Characterization of zeta (ζ): a new opioid receptor involved in growth (1989) (68)
- Carotenoid pigmentation does not reflect total non‐enzymatic antioxidant activity in plasma of adult and nestling great tits, Parus major (2007) (66)
- The opioid growth factor (OGF)-OGF receptor axis uses the p16 pathway to inhibit head and neck cancer. (2007) (65)
- Zeta (ξ), a growth-related opioid receptor in developing rat cerebellum: identification and characterization (1991) (64)
- EVALUATION OF SEQUENTIAL PLASMA AND URINARY TUMOR NECROSIS FACTOR ALPHA LEVELS IN RENAL ALLOGRAFT RECIPIENTS (1991) (62)
- Placental-type alkaline phosphatase in pregnancy and malignancy plasma: specific estimation using a monoclonal antibody in a solid phase enzyme immunoassay. (1983) (62)
- Opioid growth factor tonically inhibits human colon cancer cell proliferation in tissue culture. (1996) (60)
- Treatment of advanced pancreatic cancer with opioid growth factor: phase I (2000) (60)
- The effects of different schedules of methadone treatment on rat brain development (1977) (59)
- Low-dose naltrexone targets the opioid growth factor–opioid growth factor receptor pathway to inhibit cell proliferation: mechanistic evidence from a tissue culture model (2011) (59)
- Opioid antagonist modulation of murine neuroblastoma: a profile of cell proliferation and opioid peptides and receptors (1989) (59)
- Naltrexone's influence on neurobehavioral development (1985) (59)
- T lymphocyte proliferation is suppressed by the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: implication for the treatment of autoimmune diseases. (2011) (58)
- Insulin treatment ameliorates impaired corneal reepithelialization in diabetic rats. (2006) (57)
- Low-dose naltrexone suppresses ovarian cancer and exhibits enhanced inhibition in combination with cisplatin (2011) (57)
- Demonstration of placental and placental-like alkaline phosphatase in non-malignant human tissue extracts using monoclonal antibodies in an enzyme immunoassay. (1984) (57)
- Re-epithelialization of the rabbit cornea is regulated by opioid growth factor (1998) (56)
- Immunolocalization of tumour necrosis factor-alpha (TNF-alpha) in the placental bed of normotensive and hypertensive human pregnancies. (1998) (56)
- Reactivity of anti-human milk fat globule antibodies with synthetic peptides. (1989) (55)
- Opioids and migration, chemotaxis, invasion, and adhesion of human cancer cells (2007) (55)
- Imiquimod Upregulates the Opioid Growth Factor Receptor to Inhibit Cell Proliferation Independent of Immune Function (2008) (55)
- Preproenkephalin mRNA expression in the developing and adult rat brain. (1994) (54)
- Opioids and differentiation in human cancer cells (2005) (54)
- PERINATAL METHADONE EXPOSURE AND BRAIN DEVELOPMENT: A BIOCHEMICAL STUDY 1 (1978) (53)
- Human renal cell cancer proliferation in tissue culture is tonically inhibited by opioid growth factor. (1999) (53)
- Naloxone prolongs the survival time of mice treated with neuroblastoma. (1981) (52)
- Blister fluid cytokines in cutaneous inflammatory bullous disorders. (1999) (52)
- Cloning, sequencing, chromosomal location, and function of cDNAs encoding an opioid growth factor receptor (OGFr) in humans 1 The nucleotide sequences of human OGFr have been deposited in GenBank under accession numbers AF172449, AF172450, AF172451, AF172452, and AF172453. 1 (2000) (52)
- Re-epithelialization of the rat cornea is accelerated by blockade of opioid receptors (1998) (51)
- Heroin prolongs survival time and retards tumor growth in mice with neuroblastoma (1981) (51)
- Effects of chronic morphine administration on pregnant rats and their offspring. (1977) (50)
- Perinatal methadone exposure and its influence on the behavioral ontogeny of rats (1978) (50)
- Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis (2011) (50)
- Opioid Growth Factor Receptor in the Developing Nervous System (1993) (50)
- Immunoelectron microscopic localization of the opioid growth factor receptor (OGFr) and OGF in the cornea (2003) (49)
- Dry eye reversal and corneal sensation restoration with topical naltrexone in diabetes mellitus. (2009) (49)
- Opiates, endorphins and the developing organism: A comprehensive bibliography (1982) (49)
- Opioid antagonists inhibit the growth of metastatic murine neuroblastoma. (1983) (49)
- Modulation of human neuroblastoma transplanted into nude mice by endogenous opioid systems. (1987) (48)
- Low-affinity receptors for tumour necrosis factor-alpha, interferon-gamma and granulocyte-macrophage colony-stimulating factor are expressed on human placental syncytiotrophoblast. (1993) (48)
- Conserved expression of the opioid growth factor, [Met5]enkephalin, and the zeta (ζ) opioid receptor in vertebrate cornea (1995) (47)
- Opioid growth factor (OGF) inhibits human pancreatic cancer transplanted into nude mice. (1997) (47)
- Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinoma (2005) (46)
- Endogenous Opioids Regulate Expression of Experimental Autoimmune Encephalomyelitis: A New Paradigm for the Treatment of Multiple Sclerosis (2009) (46)
- Topically applied naltrexone restores corneal reepithelialization in diabetic rats. (2007) (46)
- Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)–OGF receptor (OGFr) axis with naltrexone: A review (2010) (45)
- Development of motor activity in young rats following perinatal methadone exposure (1979) (45)
- Learning ability in adult female rats perinatally exposed to methadone (1979) (45)
- Opioid growth factor modulates angiogenesis. (2000) (45)
- Cloning, sequencing, expression and function of a cDNA encoding a receptor for the opioid growth factor, [Met5]enkephalin 1 The nucleotide sequence of the rat OGFr has been deposited in GenBank under accession number AF 156878. 1 (1999) (44)
- A spectrin-like protein from mouse brain membranes: phosphorylation of the 235,000-dalton subunit. (1984) (44)
- Opioid growth factor ([Met5]enkephalin) prevents the incidence and retards the growth of human colon cancer. (1996) (44)
- Homeostasis of ocular surface epithelium in the rat is regulated by opioid growth factor (1997) (44)
- The opioid growth factor (OGF) and low dose naltrexone (LDN) suppress human ovarian cancer progression in mice. (2011) (44)
- Effect of chronic maternal methadone exposure on perinatal development. (1977) (43)
- Cholecystokinin receptors and PANC-1 human pancreatic cancer cells. (1993) (42)
- Opioid growth factor inhibits DNA synthesis in mouse tongue epithelium in a circadian rhythm-dependent manner. (1994) (42)
- Endogenous opioids and the growth regulation of a neural tumor. (1988) (42)
- Receptors in the Developing Nervous System (2012) (41)
- Regulation of DNA synthesis of myocardial and epicardial cells in developing rat heart by [Met5]enkephalin. (1996) (41)
- Opioid growth factor enhances tumor growth inhibition and increases the survival of paclitaxel-treated mice with squamous cell carcinoma of the head and neck (2005) (40)
- Localization of spectrin in mammalian brain (1984) (40)
- Opioid growth factor suppresses expression of experimental autoimmune encephalomyelitis (2010) (39)
- Dependence on Nuclear Localization Signals of the Opioid Growth Factor Receptor in the Regulation of Cell Proliferation (2009) (39)
- Duration of opioid receptor blockade determines biotherapeutic response. (2015) (39)
- Chronic Exposure to the Opioid Antagonist Naltrexone During Pregnancy: Maternal and Offspring Effects (1997) (39)
- Nucleocytoplasmic distribution of opioid growth factor and its receptor in tongue epithelium. (2004) (39)
- Opioid growth factor arrests the progression of clinical disease and spinal cord pathology in established experimental autoimmune encephalomyelitis (2012) (39)
- The opioid growth factor-opioid growth factor receptor axis regulates cell proliferation of human hepatocellular cancer. (2010) (39)
- Topical naltrexone accelerates full-thickness wound closure in type 1 diabetic rats by stimulating angiogenesis (2013) (38)
- Characterization of the CCK-B/gastrin-like receptor in human colon cancer. (1996) (38)
- Adult and developing human cerebella exhibit different profiles of opioid binding sites (1990) (38)
- Neural populations in the human cerebellum: estimations from isolated cell nuclei (1977) (37)
- Ontogeny of zeta (ζ), the opioid growth factor receptor, in the rat brain (1992) (37)
- B lymphocyte proliferation is suppressed by the opioid growth factor-opioid growth factor receptor axis: Implication for the treatment of autoimmune diseases. (2011) (36)
- An opioid growth factor regulates the replication of microorganisms. (1992) (36)
- Inhibition of human colon cancer by intermittent opioid receptor blockade with naltrexone. (1996) (36)
- Detection of placental-type alkaline phosphatase in ovarian cancer. (1985) (36)
- Expression of tumour necrosis factor-alpha in cryptogenic fibrosing alveolitis. (1993) (35)
- Opioid growth factor (OGF) inhibits the progression of human squamous cell carcinoma of the head and neck transplanted into nude mice. (2003) (35)
- Identification and characterization of opioid growth factor receptor in human pancreatic adenocarcinoma. (2000) (35)
- Human neuroblastoma cell growth in tissue culture is regulated by opioid growth factor. (1999) (35)
- Naloxone modulates body and organ growth of rats: Dependency on the duration of opioid receptor blockade and stereospecificity (1989) (35)
- Opiate antagonist-induced regulation of organ development (1985) (34)
- Production and characterization of polyclonal and monoclonal antibodies to the zeta (ξ) opioid receptor (1993) (34)
- Stereospecific modulation of tumorigenicity by opioid antagonists. (1985) (33)
- Featured Article: Serum [Met5]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone (2017) (33)
- Opioid growth factor – opioid growth factor receptor axis inhibits proliferation of triple negative breast cancer (2013) (33)
- Topical application of naltrexone facilitates reepithelialization of the cornea in diabetic rabbits (2010) (33)
- Ocular surface abnormalities related to type 2 diabetes are reversed by the opioid antagonist naltrexone (2014) (32)
- Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis (2015) (32)
- Opioid Receptor Blockade During Prenatal Life Modifies Postnatal Behavioral Development (1997) (32)
- Differential effects of vascular growth factors on arterial and venous angiogenesis. (2002) (32)
- Ultrastructural localization of enkephalin-like immunoreactivity in developing rat cerebellum (1990) (31)
- Demonstration and characterization of zeta (ζ), a growth-related opioid receptor, in a neuroblastoma cell line (1990) (31)
- Opioid antagonist modulation of rat heart development. (1994) (31)
- Overexpression of the opioid growth factor receptor potentiates growth inhibition in human pancreatic cancer cells. (2007) (31)
- Molecular characterization and distribution of the opioid growth factor receptor (OGFr) in mouse. (2000) (31)
- Effect of maternally administered heroin on the motor activity of rat offspring (1977) (30)
- Particle-Mediated Gene Transfer of Opioid Growth Factor Receptor cDNA Regulates Cell Proliferation of the Corneal Epithelium (2005) (30)
- Opioid antagonist (naltrexone) stimulation of cell proliferation in human and animal neuroblastoma and human fibrosarcoma cells in culture (1990) (30)
- Modulation of the opioid growth factor ([Met5]‐enkephalin)–opioid growth factor receptor axis: Novel therapies for squamous cell carcinoma of the head and neck (2012) (30)
- Naltrexone and insulin are independently effective but not additive in accelerating corneal epithelial healing in type I diabetic rats. (2009) (30)
- Targeting the opioid growth factor: Opioid growth factor receptor axis for treatment of human ovarian cancer (2013) (30)
- Radionuclide imaging of epithelial ovarian tumours with 123I-labelled monoclonal antibody (H317) specific for placental-type alkaline phosphatase. (1986) (30)
- In vivo effects of chronic treatment with [MET5]-enkephalin on hematological values and natural killer cell activity in athymic mice. (2000) (29)
- Characterization of CCK-B/gastrin-like receptors in human gastric carcinoma. (1998) (29)
- Serum placental type alkaline phosphatase in cigarette smokers. (1984) (29)
- Opioid growth factor is present in human and mouse gastrointestinal tract and inhibits DNA synthesis. (1997) (28)
- Zeta (ζ), the opioid growth factor receptor: identification and characterization of binding subunits (1993) (28)
- Overexpression of the opioid growth factor receptor downregulates cell proliferation of human squamous carcinoma cells of the head and neck. (2007) (28)
- Defects in the opioid growth factor receptor in human squamous cell carcinoma of the head and neck (2003) (28)
- Opioid gene expression in the developing and adult rat heart (1998) (28)
- Astrocyte proliferation is regulated by the OGF-OGFr axis in vitro and in experimental autoimmune encephalomyelitis (2013) (27)
- Regulation of corneal repair by particle-mediated gene transfer of opioid growth factor receptor complementary DNA. (2006) (27)
- 11 – Maternal Exposure to Opioids and the Developing Nervous System: Laboratory Findings (1992) (27)
- Endogenous Opioid Systems, Stress, and Cancer (1986) (27)
- Gene-peptide relationships in the developing rat brain: the response of preproenkephalin mRNA and [Met5]-enkephalin to acute opioid antagonist (naltrexone) exposure. (1995) (27)
- Topical treatment with the opioid antagonist naltrexone accelerates the remodeling phase of full-thickness wound healing in type 1 diabetic rats (2013) (27)
- Corneal safety of topically applied naltrexone. (2006) (26)
- Cellular dynamics of corneal wound re-epithelialization in the rat III. Mitotic activity (1999) (26)
- Regulation of cell proliferation by the opioid growth factor receptor is dependent on karyopherin β and Ran for nucleocytoplasmic trafficking (2010) (26)
- Modulation of murine neuroblastoma in nude mice by opioid antagonists. (1987) (26)
- Enhanced growth inhibition of squamous cell carcinoma of the head and neck by combination therapy of paclitaxel and opioid growth factor. (2005) (26)
- Treatment of a relapse-remitting model of multiple sclerosis with opioid growth factor (2013) (25)
- The opioid growth factor receptor in human head and neck squamous cell carcinoma. (2000) (25)
- Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis (2016) (25)
- Prevention and delay in progression of human pancreatic cancer by stable overexpression of the opioid growth factor receptor. (2008) (24)
- The autocrine derivation of the opioid growth factor, [Met5]-enkephalin, in ocular surface epithelium (1998) (24)
- A spectrin-like protein from mouse brain membranes: immunological and structural correlations with erythrocyte spectrin. (1983) (24)
- Enhanced sensitivity to methadone in adult rats perinatally exposed to methadone. (1981) (24)
- Naltrexone accelerates healing without compromise of adhesion complexes in normal and diabetic corneal epithelium (2007) (24)
- Opiates, endorphins, and the developing organism: A comprehensive bibliography, 1982–1983 (1984) (24)
- Low Dose Naltrexone for Treatment of Multiple Sclerosis: A Retrospective Chart Review of Safety and Tolerability (2015) (24)
- Perinatal Methadone Exposure in Rats (1978) (24)
- Multiple Sclerosis: Perspectives in Treatment and Pathogenesis (2017) (24)
- Opioid Receptor Blockade Throughout Prenatal Life Confers Long-Term Insensitivity to Morphine and Alters μ Opioid Receptors (1998) (23)
- Opioid growth factor and the treatment of human pancreatic cancer: a review. (2014) (23)
- Opioid growth factor (OGF) inhibits anchorage-independent growth in human cancer cells. (2004) (23)
- Topical treatment with the opioid antagonist naltrexone facilitates closure of full-thickness wounds in diabetic rats (2011) (23)
- Epithelial adhesion complexes and organ culture of the human cornea (2001) (22)
- Improved clinical behavior of established relapsing-remitting experimental autoimmune encephalomyelitis following treatment with endogenous opioids: Implications for the treatment of multiple sclerosis (2015) (22)
- Circulating immune complexes in rats bearing chemically induced tumors. I. Sequential determination during the growth of tumours at various body sites (1978) (22)
- Topical Naltrexone Is a Safe and Effective Alternative to Standard Treatment of Diabetic Wounds. (2017) (22)
- Hypophagia follows the initial hyperphagia produced by 2-deoxy-D-glucose in rats (1979) (21)
- Spontaneous episodic decreased tear secretion in rats is related to opioidergic signaling pathways. (2012) (21)
- Featured Article: Selective blockade of the OGF–OGFr pathway by naltrexone accelerates fibroblast proliferation and wound healing (2014) (21)
- β-Funaltrexamine (β-FNA) and the regulation of body and brain development in rats (1986) (21)
- Long-term treatment with low dose naltrexone maintains stable health in patients with multiple sclerosis (2016) (21)
- Opioid growth factor inhibition of a human squamous cell carcinoma of the head and neck in nude mice: dependency on the route of administration. (2004) (21)
- Opioid growth factor (OGF) for hepatoblastoma: a novel non-toxic treatment (2013) (21)
- Tumour-necrosis factor in normal plasma (1990) (20)
- Ontogeny of the opioid growth factor, [Met5]‐enkephalin, preproenkephalin gene expression, and the ζ opioid receptor in the developing and adult aorta of rat (1998) (20)
- Expression of the Opioid Growth Factor, [Met5]‐Enkephalin, and the Zeta Opioid Receptor in Head and Neck Squamous Cell Carcinoma (1997) (20)
- Soluble CD46 (membrane cofactor protein, MCP) in human reproductive tract fluids. (1996) (20)
- The opioid growth factor, [Met5]‐enkephalin, inhibits DNA synthesis during recornification of mouse tail skin (2000) (20)
- Rat Clq: similarity to human Clq in functional and compositional properties. (1978) (20)
- Prevention and delay in progression of human squamous cell carcinoma of the head and neck in nude mice by stable overexpression of the opioid growth factor receptor. (2008) (20)
- Uromodulin levels are decreased in urine during acute tubular necrosis but not during immune rejection after renal transplantation. (1993) (20)
- Cellular dynamics of corneal wound re-epithelialization in the rat I. Fate of ocular surface epithelial cells synthesizing DNA prior to wounding (1999) (19)
- The expression and function of the OGF–OGFr axis – a tonically active negative regulator of growth – in COS cells (2003) (19)
- Opioid growth factor-dependent DNA synthesis in the neonatal rat aorta. (1996) (19)
- Identification and characterization of zeta-opioid receptor in human colon cancer. (1996) (18)
- Behavioral Effects of Prenatal Exposure to Opiates1 (1983) (18)
- Comparative effects of postnatal undernutrition and methadone exposure on protein and nucleic acid contents of the brain and cerebellum in rats. (1982) (18)
- Ontogeny of preproenkephalin mRNA expression in the rat retina (1996) (18)
- Internalization of the opioid growth factor, [Met5]-enkephalin, is dependent on clathrin-mediated endocytosis for downregulation of cell proliferation. (2010) (17)
- Opioid antagonist modulation of DNA synthesis in mouse tongue epithelium is circadian dependent (1994) (17)
- Chronic exposure to the opioid growth factor, [Met5]-enkephalin, during pregnancy: Maternal and preweaning effects (2002) (17)
- Preproenkephalin gene expression and [Met5]-enkephalin levels in the developing rat heart. (1998) (17)
- Passive diffusion of naltrexone into human and animal cells and upregulation of cell proliferation. (2009) (17)
- Cellular dynamics of corneal wound re-epithelialization in the rat II. DNA synthesis of the ocular surface epithelium following wounding (1999) (17)
- Topical Naltrexone as Treatment for Type 2 Diabetic Cutaneous Wounds. (2014) (17)
- Tissue origin of serum placental-like alkaline phosphatase in cigarette smokers. (1986) (17)
- Opioid growth factor modulation of corneal epithelium: Uppers and downers (2003) (17)
- Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis (2009) (17)
- Analgesia in young and adult rats perinatally exposed to methadone. (1982) (16)
- Under-expression of the opioid growth factor receptor promotes progression of human ovarian cancer (2012) (16)
- A phase II study of a novel oral isotype-selective histone deacetylase (HDAC) inhibitor in patients with relapsed or refractory Hodgkin lymphoma (2007) (16)
- Germ cell alkaline phosphatase in human seminal plasma following vasectomy. (1992) (16)
- Expression of the opioid growth factor-opioid growth factor receptor axis in human ovarian cancer. (2012) (16)
- Isolation of placental-type alkaline phosphatase associated with human syncytiotrophoblast membranes using monoclonal antibodies. (1986) (16)
- Expression of zeta (zeta), a growth-related opioid receptor, in metastatic adenocarcinoma of the human cerebellum. (1990) (16)
- Characterization of opioid binding sites in murine neuroblastoma (1988) (16)
- Elevated Levels of Opioid Growth Factor in the Plasma of Patients with Pancreatic Cancer (2000) (15)
- Perinatal exposure to methadone alters sensitivity to drugs in adult rats. (1984) (15)
- Neuronal migration independent of glial guidance: light and electron microscopic studies in the cerebellar cortex of neonatal rats. (1985) (15)
- Elevated serum [Met5]-enkephalin levels correlate with improved clinical and behavioral outcomes in experimental autoimmune encephalomyelitis (2017) (15)
- Adaptation of Homeostatic Ocular Surface Epithelium to Chronic Treatment With the Opioid Antagonist Naltrexone (2006) (15)
- Localization of enkephalin immunoreactivity in diverse tissues and cells of the developing and adult rat (1986) (15)
- Progression of squamous cell carcinoma of the head and neck is associated with down-regulation of the opioid growth factor receptor. (2006) (15)
- Ontogeny of the opioid growth factor, [Met5]-enkephalin, and its binding activity in the rat retina (1995) (14)
- The location and orientation of mitotic figures during histogenesis of the rat cerebellar cortex (1987) (14)
- Efficacy and safety of a novel naltrexone treatment for dry eye in type 1 diabetes (2019) (13)
- Specific labeling of O6-alkylguanine-DNA alkyltransferase by reaction with O6-(p-hydroxy[3H]methylbenzyl)guanine. (1995) (13)
- Transplacental transfer of naltrexone in rats. (1997) (13)
- β-funaltrexamine (β-FNA) and neural tumor response in mice (1985) (13)
- Topical Application of Naltrexone to the Ocular Surface of Healthy Volunteers: A Tolerability Study. (2016) (12)
- Granule neurons and their significance in preparations of isolated brain cell nuclei (1976) (12)
- Inhibition of DNA synthesis in mouse epidermis by topical imiquimod is dependent on opioid receptors (2010) (12)
- Body and organ development of young rats maternally exposed to methadone. (1980) (12)
- Growth factors and hormones (1993) (12)
- Tumour necrosis factor in renal transplantation. (1991) (12)
- Characterization of zeta (zeta): a new opioid receptor involved in growth. (1989) (12)
- Exposure to the Opioid Antagonist Naltrexone throughout Gestation Alters Postnatal Heart Development (2002) (11)
- Withdrawal-like symptoms in young and adult rats maternally exposed to methadone (1981) (11)
- Methadone and brain development (1977) (11)
- Effects of chronic methadone treatment on maternal body weight and food and water consumption in rats. (1978) (10)
- Endogenous Opioids in the Etiology and Treatment of Multiple Sclerosis (2017) (10)
- Low Dose Naltrexone Treatment of Established Relapsing-RemittingExperimental Autoimmune Encephalomyelitis (2015) (10)
- TNF staining of graft biopsies in renal transplantation. (1993) (10)
- Identification and characterization of the zeta-opioid receptor in developing rat heart. (1997) (10)
- Opioids and the developing organism: A comprehensive bibliography, 1984–1988 (1989) (10)
- Intermittent blockade of OGFr and treatment of autoimmune disorders (2018) (10)
- Opioid Growth Factor, [Met5]-Enkephalin, and the Etiology, Pathogenesis, and Treatment of Gastrointestinal Cancer (1998) (10)
- Prevention of exuberant granulation tissue and neovascularization in the rat cornea by naltrexone. (2008) (10)
- Opioid growth factor receptor is unaltered with the progression of human pancreatic and colon cancers. (2006) (10)
- Transplacental transfer of the opioid growth factor, [Met5]-enkephalin, in rats (2001) (9)
- Cloning, sequencing, chromosomal wcation, and function of a cdna encoding the opioid growth factor receptor (OGFR) in humans and a modulator of ogf activity in the growth of pancreatic and colorectal cancer (2000) (9)
- Targeted overexpression of OGFr in epithelium of transgenic mice suppresses cell proliferation and impairs full-thickness wound closure. (2012) (9)
- Identification of [Met5]-enkephalin in developing, adult, and renewing tissues by reversed-phase high performance liquid chromatography and radioimmunoassay. (1997) (9)
- Expression of opioid growth factor (OGF)-OGF receptor (OGFr) axis in human nonmedullary thyroid cancer. (2008) (9)
- Urology-andrologyPlacental-type alkaline phosphatase in human seminal plasma from fertile and infertile men* (1986) (9)
- Overexpression of OGFr Downregulates Ovarian Cancer Cell Proliferation in Vitro and Inhibits Tumorigenesis (2011) (9)
- Gene expression of OGFr in the developing and adult rat brain and cerebellum (2004) (8)
- Properties of monoclonal antibodies to human tumor necrosis factor alpha (TNF alpha). (1992) (8)
- Imoaired thermal regulation in juvenile rats following perinatal methadone exposure (1979) (8)
- Opioids alter tumor cell growth and differentiation in vitro. (1984) (8)
- The Opioid Growth Factor Inhibits Established Ovarian Cancer in Nude Mice and Can Be Combined with Taxol or Cisplatin to Enhance Growth Inhibition (2011) (8)
- Opioid growth factor inhibits intimal hyperplasia in balloon-injured rat carotid artery. (2003) (8)
- Mutations in the opioid growth factor receptor in human cancers alter receptor function. (2015) (8)
- Zeta (zeta), a growth-related opioid receptor in developing rat cerebellum: identification and characterization. (1991) (8)
- Motor activity and learning ability in rats perinatally exposed to methadone. (1979) (8)
- Targeting opioid signaling in Crohn’s disease: new therapeutic pathways (2011) (7)
- Blockade of OGFr delays the onset and reduces the severity of diabetic ocular surface complications (2020) (7)
- Targeting opioidergic pathways as a novel biological treatment for advanced pancreatic cancer (2012) (7)
- Biochemical and Immunological Aspects of the Human Trophoblast Cell Surface (1987) (7)
- Comparison of mammary serum antigen (MSA) with β2-microglobulin (β2M) and carcinoembryonic antigen (CEA) assays in patients with breast cancer (1988) (7)
- Perinatal methadone exposure in rats. Effects on body and organ development. (1978) (7)
- Featured Article: Modulation of the OGF–OGFr pathway alters cytokine profiles in experimental autoimmune encephalomyelitis and multiple sclerosis (2018) (7)
- Neuronal cell deficits following maternal exposure to methadone in rats (1982) (7)
- Normal content of brain spectrin‐like protein in sph/sph mice (1984) (7)
- Spectrin expression in neuroblastoma cells (1986) (7)
- Localization of methadone in the brain of young rats by computer-assisted autoradiography (1985) (6)
- Transplacental exposure to ethylnitrosourea and its effects on body, brain, and cerebellar development in the rat. (1978) (6)
- Naltrexone is not detected in preweaning rats following transplacental exposure: implications for growth modulation. (1997) (6)
- Somatic and neurobiological alterations in the progeny of female rats treated with methadone prior to mating. (1983) (6)
- Selective opioid growth factor receptor antagonists based on a stilbene isostere. (2017) (6)
- Behavioral effects of prenatal exposure to opiates. (1983) (6)
- Dysregulation of the OGF–OGFr pathway correlates with elevated serum OGF and ocular surface complications in the diabetic rat (2020) (6)
- IMMUNE COMPLEXES IN OVARIAN CANCER (1978) (6)
- Novel treatment for triple-negative breast and ovarian cancer: endogenous opioid suppression of women's cancers (2014) (6)
- Ontogeny of zeta (zeta), the opioid growth factor receptor, in the rat brain. (1992) (6)
- A Rapid Method for Enkephalin Analysis in Tissues by Capillary Electrophoresis (1994) (6)
- Regulation of Tenon's capsule fibroblast cell proliferation by the opioid growth factor and the opioid growth factor receptor axis. (2010) (6)
- Temporal variation in cellular proliferation during recornification of mouse tail skin (1998) (4)
- A New Biotherapeutic Approach for the Treatment of Multiple Sclerosis (2013) (4)
- Placental-type alkaline phosphatase in cervical neoplasia. (1987) (4)
- Endogenous opioids and brain development (1985) (4)
- [Met5]-enkephalin preserves diffusion metrics in EAE mice (2020) (4)
- Endogenous opioids and prenatal determinants of neuroplasticity. (1997) (4)
- Nucleic acids and protein in brains and cerebella of rats transplacentally exposed to ethylnitrosourea (1981) (4)
- Placental‐type alkaline phosphatase in human seminal plasma from fertile and infertile men (1987) (4)
- Ocular surface complications result from dysregulation of the OGF-OGFr signaling pathway in female diabetic rats (2021) (4)
- Protracted analgesia in young and adult rats maternally exposed to methadone (1980) (4)
- Enkephalin Therapy Improves Relapsing-Remitting Multiple Sclerosis (2020) (4)
- Low dose naltrexone inhibits the progression of clinical disease in established relapse‐remitting experimental autoimmune encephalomyelitis ő a model for multiple sclerosis (651.3) (2014) (4)
- Proenkephalin-Derived Opioid Peptides (2006) (4)
- A search for human placental-type alkaline phosphatases using monoclonal antibodies. (1984) (4)
- Neuronal cell deficits following exposure to methadone in rats. (1982) (4)
- TNF staining of graft biopsy in renal transplantation. (1992) (3)
- Ocular surface complications in diabetes: The interrelationship between insulin and enkephalin. (2021) (3)
- C1q-binding activity of serum from allogeneically and syngeneically pregnant mice. (1979) (3)
- Endogenous Opioids and the Treatment of Multiple Sclerosis (2013) (3)
- beta-Funaltrexamine (beta-FNA) and the regulation of body and brain development in rats. (1986) (3)
- Effect of chronic heroin exposure on pregnant rats and their offspring. (1982) (3)
- Tumour necrosis factor (TNF) and inflammation (1992) (3)
- Dysregulation of the OGF-OGFr pathway and associated diabetic complications. (2021) (3)
- Proenkephalin-Derived Peptides (2013) (3)
- Naltrexone as a Novel Therapeutic for Diabetic Corneal Complications (2020) (3)
- Sex differences in the magnitude of diabetic ocular surface complications: Role of serum OGF (2021) (2)
- Blockade of the OGF-OGFr pathway in diabetic bone (2019) (2)
- The effect of chronic heroin administration on survival of mice treated with neuroblastoma. Abstr. (1980) (2)
- Endocytosis for Downregulation of Cell Proliferation (2010) (2)
- β-endorphin and opioid growth factor as biomarkers of physical ability in multiple sclerosis. (2021) (2)
- Opioid growth factor receptor (OGFR) expression is downregulated with progression of triple negative breast cancer (2015) (2)
- Abstract 697: Inhibition of Cancer Progression by Upregulation of the Opioid Growth Factor (OGF) - OGF Receptor (OGFr) Axis Using Imquimod or Low Dose Naltrexone (2010) (2)
- Serological and tissue localization of placental alkaline phosphatase using monoclonal antibodies in breast and ovarian cancer. (1984) (2)
- Mechanisms underlying the action of endogenous opioid systems in neural cancer (1987) (2)
- Research report Cellular dynamics of corneal wound re-epithelialization in the rat (2000) (2)
- Featured Article: Nuclear export of opioid growth factor receptor is CRM1 dependent (2016) (2)
- Treatment of advanced pancreatic cancer patients with opioid growth factor (2000) (2)
- beta-Funaltrexamine (beta-FNA) and neural tumor response in mice. (1985) (2)
- [3H] naloxone binding in the brains of young rats perinatally exposed to methadone (1984) (1)
- Properties of monoclonal antibodies to human tumour necrosis factor alpha (TNFa). (1992) (1)
- Opioid Growth Factor and Retinal Morphogenesis (1995) (1)
- Naltrexone as a Novel Treatment for Diabetic Keratopathy: Toxicity Studies (2006) (1)
- Sex Differences in Diabetic Ocular Surface Complications and Dysregulation of the OGF-OGFr Pathway (2022) (1)
- Opioid growth factor reverses the progression of clinical disease in established relapse‐remitting experimental autoimmune encephalomyelitis ő a model for multiple sclerosis (651.2) (2014) (1)
- Prenatal naltrexone exposure adversely alters postnatal cardiac development: A model for dilated cardiomyopathy (2003) (1)
- Opioid Antagonists Enhance Diabetic Wound Closure: A New Therapy (2014) (1)
- Research report Conserved expression of the opioid growth factor, (MetS)enkephalin, and the zeta (~') opioid receptor in vertebrate cornea (1995) (1)
- POMC-Derived Opioid Peptides (2013) (1)
- Stability of Opioid Growth Factor ([Met5]‐Enkephalin) in Solution Using HPLC and Photodiode Array Detection (2006) (1)
- Comparison of mammary serum antigen (MSA) with beta 2-microglobulin (beta 2M) and carcinoembryonic antigen (CEA) assays in patients with breast cancer. (1988) (1)
- Characteristics and classification of high-grade B-cell lymphomas in resource-limited settings (2014) (1)
- QS297. Opioid Growth Factor Inhibits Cell Replication and DNA Synthesis of Hepatocellular Cancer In Vitro Through a Receptor Mediated Mechanism (2009) (0)
- QS106. The Opioid Growth Factor Axis in Human Thyroid Cancer (2008) (0)
- Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis (2015) (0)
- Opioid Growth Factor Decreases Neointima Formation in the Rat Carotid Artery (1998) (0)
- Corneal Wound Healing In The Diabetic Rat Is Enhanced By Naltrexone - An Opioid Antagonist (2002) (0)
- Serum enkephalin levels correlate with EAE disease severity (2017) (0)
- Encephalomyelitis : A New Paradigm for the Treatment of Multiple Sclerosis Endogenous Opioids Regulate Expression of Experimental Autoimmune (2009) (0)
- TNF staining of graft biopsy in renal transplantation (1992) (0)
- Topical Naltrexone Reverses Dry Eye in Mice with Type 2 Diabetes (db/db) (2011) (0)
- Nucleocytoplasmic Distribution Of Opioid Growth Factor (OGF) And OGF Receptor In Rat Cornea (2002) (0)
- Production and characterization of polyclonal and monoclonal antibodies to the zeta ( s r ) opioid receptor (2002) (0)
- Gene Expression of the Opioid Growth Factor Receptor and the Regulation of Corneal Re–Epithelialization (2006) (0)
- Methods and compositions for the treatment of dry eye (2010) (0)
- Topical Naltrexone Restores Normal Tear Production in Rats (2011) (0)
- Subconjunctival Administration of Opioid Growth Factor Prolongs Longevity of Glaucoma Filtering Surgery without Tissue Toxicity in Rabbits (2015) (0)
- Corneal Vascularization and Granulation Tissue Formation Accompanying Delayed Corneal Epithelial Wound Healing in Diabetic Rats is Prevented by Topical Treatment With Naltrexone (2007) (0)
- Cell cycle alterations and the inhibition of humanpancreatic cell replication by opioid growth factor (2000) (0)
- Low-dose naltrexone reduced anxiety in persons with multiple sclerosis during the COVID-19 pandemic (2022) (0)
- Opioid growth factor receptor: Anatomical distribution and receptor colocalization in neurons of the adult mouse brain (2023) (0)
- Growth of Triple Negative Human Breast Cancer Cells is Regulated by the OGF‐OGFr Axis (2012) (0)
- POTENTIAL INVOLVEMENT OF GPR 119 RECEPTOR IN THE EFFECTS OF NOVEL FAT SENSOR OEA ON TASTE PREFERENCES AND BODY WEIGHT REGULATION TO HIGH (2016) (0)
- Timing of treatment with an endogenous opioid alters immune response and spinal cord pathology in female mice with experimental autoimmune encephalomyelitis (2021) (0)
- Transgenic Mice Overexpressing OGFr Have Delayed DNA Synthesis and Epithelial Repair (2011) (0)
- Carcinogenic Impurities in Food and Color Additives-An Analysis of Presumptive Risk Levels (1991) (0)
- ROLES OF PI 3-KINASE AND PDK-1 IN ROD PHOTORECEPTOR DIFFERENTIATION (2013) (0)
- Opioid growth factor (OGF) prevents relapses in mice with relapsing‐remitting EAE, a model for multiple sclerosis (2013) (0)
- Topical Treatment With Naltrexone and Insulin Does Not Have an Additive Effect on Accelerating Corneal Epithelial Healing in Type I Diabetic Rats (2008) (0)
- R048: (Met5)-Enkephalin Levels in the Plasma of SCCHN Are Reduced following Surgery (2003) (0)
- Topical insulin enhances corneal repair in Type 1 diabetic rats (2007) (0)
- Identification of Zeta (S) Opioid Receptor Binding Polypeptides in Rat Cerebellum (1993) (0)
- Abstract 4153: Short term opioid receptor blockade inhibits cancer cell proliferation independent of immune function by upregulation of the OGF-OGFr axis: A tissue culture model of low dose naltrexone (LDN) (2010) (0)
- Contents, Vol. 31, 1977 (1977) (0)
- Naltrexone blockade of OGFr enhances cutaneous wound closure in diabetic rats (2021) (0)
- TRPM 2 INHIBITION INCREASES OXIDATIVE STRESS AND REDUCES TUMOR GROWTH IN NEUROBLASTOMA THROUGH MODULATION OF GSH (2017) (0)
- Effects of Perinatal Exposure to Opioid Agonists and Antagonists on Central Nervous System Development (1991) (0)
- Topical Insulin Enhances Corneal Epithelial Healing in Type I Diabetic Rats (2007) (0)
- Subject Index Vol. 5, 1982 (1982) (0)
- Effects of Local Opioid Antagonist on Diabetic Fracture Rat Model (2018) (0)
- Blockade of the opioid growth factor receptor with naltrexone enhances wound repair in type 2 db/db mice (734.5) (2014) (0)
- Corneal Epithelial Adhesion Complexes Are Not Altered in Diabetic Rats Following Topical Naltrexone Therapy (2007) (0)
- Ran for nucleocytoplasmic trafficking and β Regulation of cell proliferation by the opioid growth factor receptor is dependent on karyopherin (2010) (0)
- Treatment of clinically isolated syndrome with low dose (2015) (0)
- Book Review / Varia (1977) (0)
- Modulation of the OGF‐OGFr Axis Suppresses Progression of Head and Neck Cancer (2011) (0)
- Topical Naltrexone Reverses Dry Eye in Normal Rats (2011) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Patricia J. Mclaughlin?
Patricia J. Mclaughlin is affiliated with the following schools:
